• Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
  • Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
  • Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
  • Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
  • Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
  • Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil

Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
Purity: >99%
Product Name: Gemfibrozil
Samples:
US$ 100/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung Gemfibrozil
Name
Gemfibrozil Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Treatment Hyperlipidemia
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
25812-30-0
Mf
C15h22o3
MW
250.33338
Boiling Point
394.7 °c at 760 Mmhg
Density
1.044
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
1000kg/Month

Product Description

Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
Product Description
Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder GemfibrozilTreatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
Product Details
Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
Product name Gemfibrozil
Appearance White powder
CAS NO. 25812-30-0
MF C15H22O3
MW 250.33338
Gemfibrozil, 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid (Lopid), is a congener of clofibratethat was used first in the treatment of hyperlipoproteinemia inthe mid-1970s. Its mechanism of action and use are similar tothose of clofibrate. Gemfibrozil reduces plasma levels ofVLDL triglycerides and stimulates clearance of VLDL fromplasma. The drug has little effect on cholesterol plasma levelsbut does cause an increase of HDL.

Gemfibrozil is absorbed quickly from the gut and excretedunchanged in the urine. The drug has a plasma half-life of1.5 hours, but reduction of plasma VLDL concentration takesbetween 2 and 5 days to become evident. The peak effect of its hypolipidemic action may take up to 4 weeks to becomemanifest.
Application&Function
Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil1. Used for the treatment of hyperlipidemia. The agent is suitable for treatment of severe type IV or type V hyperlipoproteinemia patients with high-risk coronary heart disease who had no response to treatments such as dietary control or weight loss. It is also applicable to type II-b hyperlipoproteinemia patients with high-risk coronary heart disease who had failed to respond to treatments such as dietary control, weight loss, or other lipid-regulating medications.

2. Used as a lipid-regulating agent. It can significantly reduce the levels of triglyceride and cholesterol in blood, and can significantly reduce very low-density lipoprotein (VLDL) levels and increase high-density lipoprotein (HDL) levels, but it has little effect on low-density lipoprotein (LDL) levels. Clinically, it can be used in patients with all types of lipid metabolism disorders, such as primary and secondary hyperlipoproteinemias, hypercholesterolemias, hypertriglyceridemias, mixed hyperlipidemias, and lipid metabolism disorders caused by diabetes. It can also be used to prevent the occurrence of myocardial infarction.

3. The product belongs to phenoxy aromatic acid antihyperlipidemics, which is a group of drugs developed on the basis of clofibrate including fenofibrate, Etofylline Clofibrate, Bijiangzhi, gemfibrozil and so on. These drugs were similar in chemical structure. Clofibrate has rather serious adverse reactions (which include elevating the occurrence of gallstone). Improved drugs are more effective than clofibrate, with mild and fewer adverse reactions.

4. A lipid-regulating drug that can reduce cholesterol and triglyceride levels in blood.
Specification
Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder GemfibrozilTreatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder GemfibrozilTreatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder GemfibrozilTreatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder GemfibrozilTreatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
Treatment Hyperlipidemia CAS 25812-30-0 Gemfibrozil Pharmaceutical Gemfibrozil Raw Powder Gemfibrozil
 
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP